Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Atara Biotherapeutics, Inc.

NASDAQ: ATRAHealthcare / Biotechnology / USA
42.62+2.42+6.02%Vol 280 6731Y Perf 187.91%
Dec 10th, 2018 14:41
BID42.52 ASK42.73
Open40.50 Previous Close40.20
Pre-Market- After-Trading40.20
 - -%  - -%
Target Price
47.50 
Analyst Rating
Moderate Buy 2.14
Potencial %
11.87 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-97/-99 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-98/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-98/-100 
Income Ranking
 —    -
Market Cap (mil)1 946 
Earnings Rating
Sell
Price Range Ratio 52wk %
70.53 
Earnings Date
8th Nov 2018

Today's Price Range

40.0042.95

 

52wk Range

14.3154.45

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
6.26%
3 Months
1.13%
6 Months
-10.67%
1 Year
187.91%
3 Years
16.59%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ATRA42.622.42006.02
AAPL169.571.08000.64
GOOG1 044.157.57000.73
MSFT107.152.33002.22
XOM76.06-1.5800-2.04
WFC48.93-1.3300-2.65
JNJ145.32-0.1100-0.08
FB142.064.64003.38
GE6.90-0.1100-1.57
JPM101.49-1.8000-1.74
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
13.50
Current Ratio
13.80
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
4.52
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-9.70
Cash Flow Per Share
-3.68
Price to Tangible Book
4.52
Book Value per Share
8.83
Enterprise Value (in ths.)
1 459 110
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-37.71
ROE last 12 Months
-61.29
Return on Assets (5Y Avg)
-17.82
ROA last 12 Months
-55.50
Return on Capital (5Y Avg)
-
ROC last 12 Months
-61.08
Return on invested Capital Q
-13.64
Return on invested Capital Y
-55.37
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.18-1.29-9.32
Q02 2018-0.97-1.15-18.56
Q01 2018-0.93-1.05-12.90
Q04 2017-1.15-1.150.00
Q03 2017-1.03-1.020.97
Q02 2017-0.91-0.94-3.30
Q01 2017-0.77-0.88-14.29
Q04 2016-0.91-0.6330.77
Earnings Per EndEstimateRevision %Trend
12/2018 QR-1.31-8.26Negative
12/2018 FY-4.82-5.24Negative
3/2019 QR-1.35-8.00Negative
12/2019 FY-5.50-7.42Negative
Next Report Date-
Estimated EPS Next Report-1.18
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume280 673
Shares Outstanding (in ths.)45 650
Trades Count1 725
Dollar Volume10 128 234
Avg. Volume691 010
Avg. Weekly Volume494 256
Avg. Monthly Volume565 089
Avg. Quarterly Volume593 930

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

67%33%

Bearish Bullish

63%37%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (57.14 %)
4 (57.14 %)
4 (57.14 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (28.57 %)
2 (28.57 %)
2 (28.57 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (14.29 %)
1 (14.29 %)
1 (14.29 %)
RatingModerate Buy
2.14
Moderate Buy
2.14
Moderate Buy
2.14

There are no comments yet.

News